Guard Therapeutics: Progression as Planned with New Additions.

Research Note

2020-08-20

12:01

Redeye gives a short comment regarding today’s report for the second quarter from Guard Therapeutics.

NF

LS

Nima Faroghi

Ludvig Svensson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.